Position in RPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$32,220,489
-$3,514,517 QoQ
Shares Held
671,680
-27.4% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 50%
Shared 50%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Derivatives in RPRX
reported options exposure · as of Mar 31, 2026CallValue
$2,168,244
CallShares
45,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026TUDOR INVESTMENT CORP ET AL holds $333,275,952 across 117 Biotechnology names. RPRX ranks #2 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACLX |
Arcellx, Inc.
|
462,588 | $53,114,354 | |
| 2 | RPRX |
Royalty Pharma plc
This page
|
671,680 | $32,220,489 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
495,591 | $28,818,616 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
650,000 | $26,149,500 | |
| 5 | TERN |
Terns Pharmaceuticals, Inc.
|
267,520 | $14,103,654 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
900,000 | $13,014,000 | |
| 7 | ABVX |
Abivax S.A.
|
101,611 | $11,314,384 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
87,852 | $8,543,607 |
All Filings in RPRX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $32,220,489 | 671,680 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $2,168,244 | 45,200 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $35,735,006 | 924,819 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $30,476,098 | 863,835 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $23,157,778 | 642,736 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $22,654,421 | 727,736 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $18,750,538 | 735,027 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $14,392,622 | 508,753 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,240,625 | 312,500 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $487,377 | 16,048 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,988,491 | 70,790 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,668,813 | 208,873 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,873,295 | 60,940 | Shares | Defined | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||